NIMODIPINE Side Effects

5935184-7 | Familial Hemiplegic Migraine, Grand Mal Convulsion
on Oct 21, 2008 Male patient from NORWAY , 16 years of age, was diagnosed with cerebral vasoconstriction, nausea (What is nausea?), migraine (What is migraine?), familial hemiplegic migraine and was treated with Nimodipine (View Usage). Patient experienced the following unwanted or unexpected effects: familial hemiplegic migraine, grand mal convulsion. Nimodipine dosage: . During the same period patient was treated with VERAPAMIL (View Verapamil Review and Verapamil Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), KETOBEMIDONE (View Ketobemidone Review and Ketobemidone Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ). Patient was hospitalized.

5614954-9 | Renal Failure Acute
Patient was taking Nimodipine (View Usage). Patient had the following side effects: renal failure acute on Jan 29, 2008 from SPAIN Additional patient health information: Male patient , 80 years of age, weighting 187.4 lb, was diagnosed with metastatic renal cell carcinoma and. Nimodipine dosage: . During the same period patient was treated with SUNITINIB MALATE (View Sunitinib Malate Review and Sunitinib Malate Label ), COZAAR (View Cozaar Review and Cozaar Label ). Patient was hospitalized.

5610608-3 | Blood Pressure Decreased, Breath Sounds Abnormal, Cerebrovascular Accident, Liver Scan Abnormal, Oxygen Saturation Decreased
Adverse event was reported on Jan 23, 2008 by a Female patient taking Nimodipine (View Usage) (Dosage: 2 Poked Caps, Under The Tongue 2 Caps, Single, Intravenous) . Location: UNITED STATES , 63 years of age, weighting 140.0 lb, After Nimodipine was administered, patient had the following side effects: blood pressure decreased, breath sounds abnormal, cerebrovascular accident, liver scan abnormal, oxygen saturation decreased. Patient was hospitalized.

5025044-0 | Gingival Bleeding, Haemorrhage, Increased Tendency To Bruise
on Jun 08, 2006 Female patient from UNITED STATES , 48 years of age, weighting 140.0 lb, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Nimodipine (View Usage). Patient experienced the following unwanted or unexpected effects: gingival bleeding, haemorrhage, increased tendency to bruise. Nimodipine dosage: 1 Q Am Po. During the same period patient was treated with LAMICTAL (View Lamictal Review and Lamictal Label ), ATIVAN (View Ativan Review and Ativan Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), CYTOMEL (View Cytomel Review and Cytomel Label ), DEXEDRINE (View Dexedrine Review and Dexedrine Label ).


4886868-3 | Asphyxia, Disease Recurrence, Dyspnoea, Heart Rate Increased, Pyrexia, Subarachnoid Haemorrhage
on Jan 10, 2006 Male patient from CHINA , 67 years of age, was diagnosed with prophylaxis, vasospasm and was treated with Nimodipine (View Usage). Patient had the following side effects: asphyxia, disease recurrence, dyspnoea, heart rate increased, pyrexia, subarachnoid haemorrhage. Nimodipine dosage: 10 Mg, Total Daily, Intravenous. During the same period patient was treated with CEREBROLYSIN (View Cerebrolysin Review and Cerebrolysin Label ), SODIUM CYTIDINE TRIPHOSPHATE (View Sodium Cytidine Triphosphate Review and Sodium Cytidine Triphosphate Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), AZOSEMIDE (View Azosemide Review and Azosemide Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ).

4869718-0 | Asphyxia, Disease Recurrence, Dyspnoea, Infection, Pyrexia, Subarachnoid Haemorrhage, Tachycardia
Patient was taking Nimodipine (View Usage). After Nimodipine was administered, patient had the following side effects: asphyxia, disease recurrence, dyspnoea, infection (What is infection?), pyrexia, subarachnoid haemorrhage, tachycardia on Dec 15, 2005 from CHINA Additional patient health information: Male patient , 67 years of age, was diagnosed with prophylaxis, vasospasm and. Nimodipine dosage: 10 Mg, Total Daily, Intravenous. During the same period patient was treated with CEREBROLYSIN (View Cerebrolysin Review and Cerebrolysin Label ), SODIUM CYTIDINE TRIPHOSPHATE (View Sodium Cytidine Triphosphate Review and Sodium Cytidine Triphosphate Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), AZOSEMIDE (View Azosemide Review and Azosemide Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ).